Navigation Links
PharmaNet Development Group To Showcase Innovative Solutions and Poster Presentations at AAPS 2009
Date:10/12/2009

PRINCETON, N.J., Oct. 12 /PRNewswire/ -- PharmaNet Development Group, Inc., a leading provider of clinical development services to innovative pharmaceutical, biotechnology, generic drug and medical device companies, today announced that the Company and its subsidiaries Anapharm and Taylor Technology will be showcasing a range of innovative solutions at the 2009 AAPS Annual Meeting and Exposition.

Taylor Technology and Anapharm representatives will be discussing their offerings in method development and validation, bioanalytical mass spectrometry and immunochemistry. For more information on PharmaNet Development Group and the offering of its subsidiaries, please visit the PharmaNet booth 1739 at AAPS 2009 at the Los Angeles Convention Center, Los Angeles, California from November 8 - 11, 2009.

Attendees of the conference are invited to attend a series of poster presentations by PharmaNet employees covering a wide range of scientific topics and will include the following topics:

Tuesday, November 10, 2009

Presentations from 11:00 am to 12:00 pm, Posters available from 8:00 am to 12:00 pm

Importance of Using Physiologically-Relevant Concentrations in the Evaluation of Metabolite Back-Conversion, Presenter: Betty Stamatiou, Co-Authors: Sylvain Lachance, Ann Levesque, Robert Masse, Betty Stamatiou

A Useful Derivatization Tool to Enhance Sensitivity for the Quantitation of Phenylephrine at Low Picograms levels by LCMSMS, Presenter: Ann Levesque, Co-Authors: Serge Auger, Sylvain Lachance, Ann Levesque, Robert Masse

Relative Instability of Deuterated Internal Standard under Different pH Conditions and According to Deuterium Atoms Location, Presenter: Nathalie Pelletier, Co-Authors: Nadine Boudreau, Sylvain Lachance, Ann Levesque, Robert Masse, Nathalie Pelletier, Caroline Savard

Precautions Required to Quantify a Thermally Labile [beta]-lactone in Human Plasma by LC/MS/MS, Presenter: Stephanie Turcotte, Co-Authors: Sylvain Lachance, Ann Levesque, Robert Masse, Stephanie Turcotte

Summation of Multiple Transitions Monitoring in LC/MS/MS to Enhance Signal to Noise and to Reduce Variability, Presenter: Sylvain Lachance, Co-Authors: Philippe Belanger, Jean Couture, Sebastien Gagne, Sylvain Lachance, Ann Levesque, Isabelle Levesque, Robert Masse, François Viel

A Useful Computerized Tool for the Evaluation of Bioanalytical Methods and Study Sample Analysis Robustness, Presenter: Nadine Boudreau, Co-Authors: Patrice Arcand, Serge Auger, Philippe Belanger, Nadine Boudreau, Ann Levesque, Robert Masse

How to Avoid Metabolite Back-Conversion: Tests Performed to Prove the Absence of Back-Conversion for Clopidogrel LCMSMS Method in Human Plasma, Presenter: Guy Havard, Co-Authors: Marie-Eve Coulombe, Guy Havard, Sylvain Lachance, Ann Levesque, Robert Masse

Lipemic Effect Evaluation on Detection Variability Using Natural and Synthetic Lipemic Plasma in LC/MS/MS Method, Presenter: Sofi Gagnon-Carignan, Co-Authors: Sofi Gagnon-Carignan, Sylvain Lachance, Nancy Lampron, Ann Levesque, Robert Masse

Trouble-Shooting of Least-Expected Causes in Bioanalytical Method Development and Application, Presenter: Aimin Tan, Co-Authors: Sebastien Gagne, Robert Masse, Valerie Montminy, Adrien Musuku, Aimin Tan

Wednesday, November 11, 2009

Presentations from 11:00 am to 12:00 pm, Posters available from 8:00 am to 12:00 pm

Quantification of the Impact of Bioanalytical Method Variability on Bioequivalence Primary Pharmacokinetic Parameters, Presenter: Audrey Saint-Laurent, Co-Authors: Audrey Lainesse, Robert Masse, Audrey Saint-Laurent, Eric Shink, Mario Tanguay

Thursday, November 12, 2009

Presentations from 11:00 am to 12:00 pm, Posters available from 8:00 am to 12:00 pm

Enantiomeric Separation in Chiral Chromatography Enhanced by Propionic Anhydride as a Chemical Modifier, Presenter: Robert Masse, Co-Authors: Nicolas Jean, Sylvain Lachance, Ann Levesque, Robert Masse

For more information about PharmaNet and its subsidiaries' comprehensive range of services, please visit the PharmaNet Development Group booth 1739 at AAPS 2009. Alternatively, please email earlystage@pharmanet.com or visit www.pharmanet.com

About PharmaNet Development Group, Inc.

PharmaNet Development Group, Inc., a global drug development services company, provides a comprehensive range of services to the pharmaceutical, biotechnology, generic drug and medical device industries. The Company offers early and late stage consulting, Phase I clinical studies and bioanalytical analyses, and Phase II, III and IV clinical development programs. With approximately 2,300 employees and 40 facilities throughout the world, PharmaNet is a recognized leader in outsourced clinical development.

For further press information please contact Celine Callender, The Scott Partnership, 1 Whiteside, Station Road, Holmes Chapel, Cheshire CW4 8AA, United Kingdom. Phone +44 1477 539539, Fax +44 1477 539540, Email: pharmanet@scottpr.com

    Media Contact Information
    Name: Celine Callender/Laura Browne     Anne-Marie Hess
          Scott Partnership                 PharmaNet Development Group, Inc.
    Phone: +44 1477 539539                  (609) 951-6842
    Email: pharmanet@scottpr.com            ahess@pharmanet.com

SOURCE PharmaNet Development Group, Inc.


'/>"/>
SOURCE PharmaNet Development Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. Promising Cystic Fibrosis Compound on Track for Development
3. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
4. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
5. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
6. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
7. New Company Starts, Bridging the Development Gap in the Discovery of Cancer Drugs
8. Quest Diagnostics Introduces ClariSure(TM) Test for Identifying Chromosome Abnormalities Associated With 85 Developmental Disorders in Children
9. WorldHeart Announces Further Milestone in Miniaturized Assist Pump Development
10. EntreMed Raises $20 Million to Support Clinical Development Program
11. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/2/2017)... 2017   Marshall County Hospital in Benton, Kentucky has ... of hospital-acquired infections (HAIs). The new addition, Tru-D SmartUVC , short for "total room ... pathogens such as C. diff , MRSA, MERS, Ebola and more. ... Tru-D SmartUVC ... Tru-D in action in a patient room ...
(Date:7/31/2017)... , July 31, 2017 Three Tru-D SmartUVC robots ... South Korea . Tru-D, short for "Total Room Ultraviolet Disinfection," ... rooms after an environmental services (ES) professional cleans the area with traditional ... Tru-D ... "Although the BAACH has ...
(Date:7/27/2017)... Pa., July 27, 2017  West Pharmaceutical Services, Inc. ... results for the second-quarter 2017 and updated financial guidance ... Second-Quarter 2017 Highlights Reported net ... over the prior-year quarter. Net sales at constant currency ... reported-diluted EPS was $0.51, compared to $0.60 in the ...
Breaking Medicine Technology:
(Date:8/16/2017)... NJ (PRWEB) , ... August 16, 2017 , ... ... is offering an opportunity for men and women to train as hospice ... families dealing with life-limiting illness. For over 30 years, the agency has trained ...
(Date:8/16/2017)... ... August 16, 2017 , ... First Choice Emergency Room , the ... J. Harrison, as the new Medical Director of its Sienna Plantation facility. , ... of our Sienna Plantation location,” said Dr. Michael (Derek) Caraway, Area Medical Director of ...
(Date:8/16/2017)... ... August 16, 2017 , ... Rollon Skin ... anti-aging skincare solutions, recently announced the launch of two new skincare products, Prache ... effective alternative to expensive plastic surgery or in-patient cosmetic dermatological procedures. , “Prache ...
(Date:8/16/2017)... West Orange, NJ (PRWEB) , ... August 16, 2017 , ... With low back pain ... not even know what causes its kissing cousin – upper back pain. But this equally ... bevy of treatment options, according to Kaixuan Liu, MD, PhD , founder and president ...
(Date:8/16/2017)... ... 2017 , ... “Faith, Through The Eyes of A Child” is the creation of published author, ... looking down at her. Since she was in such great pain, my mother thought that ... everything went well. It wasn’t until I was about eight years old, when I had ...
Breaking Medicine News(10 mins):